Fig. 2From: Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort studyComparison of progression-free survival rates by intention-to-treat (a) or per-protocol (b) analyses. CI confidence intervalBack to article page